India’s Alembic Pharma opens anticancer manufacturing plant in Gujarat

Alembic Pharmaceuticals opens oncology manufacturing facility in India.

API drugmaker Alembic Pharmaceuticals is diving into the oncology arena by opening an anticancer manufacturing facility at Panelav, Halol, in Gujarat.

The company, best known for manufacturing anti-infective, analgesic and cough and cold therapies, said the facility will manufacture 60 million tablets and capsules and about 20 million vials of liquid injectable and lyophilized concentrates.

Chirayu Amin, chairman of Alembic, said the company expects to export oncology products to the U.S., Middle East, North Africa, Australia and South Africa. The facility boasts the latest manufacturing equipment from Germany, Belgium, the U.K., and China, he said.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Alembic managing director Pranav Amin said the company is looking to invest about $23 million as part of its expansion plan over the next three years, the Economic Times Healthworld reported.

Suggested Articles

Amid China's tighter grip on antibiotics use, Lilly sold Chinese rights to two legacy antibiotics and a manufacturing facility to China's Eddingpharm.

Alvogen is recalling two lots of mismarked fentanyl patches because they could lead to overdoses.

The recall from the U.S. of tainted blood pressure medicines reached new heights as India’s Torrent Pharmaceuticals recalled 104 lots of losartan.